Review of long-term complications and functional outcomes of ileoanal pouch procedures in patients with inflammatory bowel disease

被引:7
|
作者
Hassan, Yusuf [1 ,4 ]
Connell, William R. [2 ]
Rawal, Alisha [3 ]
Wright, Emily K. [1 ,2 ]
机构
[1] Univ Melbourne, Melbourne Med Sch, Melbourne, Australia
[2] St Vincents Hosp, Dept Gastroenterol, Melbourne, Australia
[3] Grampians Hlth, Gen HMO Stream, Ballarat, Australia
[4] 12 Summit Crescent, Glen Waverley, Vic 3150, Australia
关键词
Crohn's disease; ileoanal pouches; inflammatory bowel disease; pouch failure; pouch fistula; pouchitis; ulcerative colitis; ANAL ANASTOMOSIS; ULCERATIVE-COLITIS; RESTORATIVE PROCTOCOLECTOMY; INCREASED RISK; IPAA; MANAGEMENT; NEOPLASIA; INCREASE; FAILURE; GENDER;
D O I
10.1111/ans.18490
中图分类号
R61 [外科手术学];
学科分类号
摘要
BackgroundIn medically refractory Ulcerative Colitis (UC), proctocolectomy with ileoanal pouch procedure (IAPP) is the preferred continence-preserving surgical option. Functional outcomes post-surgery and long-term complication rates in the biologic era remain ambiguous. This review primarily aims to provide an update on these outcomes. Secondarily, risk factors associated with chronic pouchitis and pouch failure are explored. MethodsTwo online databases (MEDLINE and EMBASE) were searched on 4 October 2022 for English studies from 2011-present relating to long-term outcomes of IAPP in inflammatory bowel disease (IBD) patients. Adult patients with 12 month follow-up were included. Studies focused on 30-day post-operative outcomes, non-IBD patients or studies including less than 30 patients were excluded. ResultsFollowing screening and full-text review of 1094 studies, 49 were included. Median sample size was n = 282 (IQR: 116-519). Median incidences for chronic pouchitis and pouch failure were 17.1% (IQR: 12-23.6%) and 6.9% (IQR: 4.8-10.8%), respectively. Upon multivariate analysis, chronic pouchitis development was most significantly associated with pre-operative steroid use, pancolitis and extra-intestinal IBD manifestations, whilst pouch failure was most significantly associated with pre-operative diagnosis of Crohn's disease (compared to UC), peri-operative pelvic sepsis and anastomotic leak. Overall patient satisfaction was very high with four included studies reporting greater than 90% satisfaction rates. ConclusionLong-term complications for IAPP were common. However, despite this, patient satisfaction post-IAPP was high. Up-to-date knowledge of complication rates and their risk factors improves pre-operative counselling, management planning and patient outcomes.
引用
收藏
页码:1503 / 1509
页数:7
相关论文
共 50 条
  • [41] Is ileoanal pouch excision a destination therapy for Inflammatory Bowel Disease? Data from a quaternary pouch referral center
    Choi, S.
    Lightner, A.
    Lipman, J.
    Hull, T.
    Steele, S.
    Holubar, S.
    Rieder, F.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S337 - S338
  • [42] Endoscopic Phenotype of the J Pouch in Patients With Inflammatory Bowel Disease: A New Classification for Pouch Outcomes
    Akiyama, Shintaro
    Ollech, Jacob E.
    Rai, Victoria
    Glick, Laura R.
    Yi, Yangtian
    Traboulsi, Cindy
    Runde, Joseph
    Cohen, Russell D.
    Skowron, Kinga B.
    Hurst, Roger D.
    Umanskiy, Konstantin
    Shogan, Benjamin D.
    Hyman, Neil H.
    Rubin, Michele A.
    Dalal, Sushila R.
    Sakuraba, Atsushi
    Pekow, Joel
    Chang, Eugene B.
    Rubin, David T.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (02) : 293 - +
  • [43] Inflammatory bowel disease: long-term therapeutic challenges
    Ashton, James J.
    Green, Zachary
    Kolimarala, Vinod
    Beattie, R. Mark
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 13 (11) : 1049 - 1063
  • [44] LONG-TERM NATURAL HISTORY OF SYMPTOMS AND OUTCOMES IN PATIENTS WITH FUNCTIONAL BOWEL DISORDERS
    Chen, Binrui
    Du, Lijun
    Kim, John J.
    Zhang, Yawen
    Dai, Ning
    GASTROENTEROLOGY, 2020, 158 (06) : S852 - S853
  • [45] Long-term safety of vedolizumab for inflammatory bowel disease
    Loftus, Edward V., Jr.
    Feagan, Brian G.
    Panaccione, Remo
    Colombel, Jean-Frederic
    Sandborn, William J.
    Sands, Bruce E.
    Danese, Silvio
    D'Haens, Geert
    Rubin, David T.
    Shafran, Ira
    Parfionovas, Andrejus
    Rogers, Raquel
    Lirio, Richard A.
    Vermeire, Severine
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (08) : 1353 - 1365
  • [46] LONG-TERM PROGNOSIS OF INFLAMMATORY BOWEL-DISEASE
    FARMER, RG
    POSTGRADUATE MEDICINE, 1981, 70 (04) : 124 - &
  • [47] IS ILEOANAL POUCH EXCISION A DESTINATION THERAPY FOR INFLAMMATORY BOWEL DISEASE? DATA FROM A QUATERNARY POUCH REFERRAL CENTER
    Choi, Sarah
    Lightner, Amy
    Lipman, Jeremy
    Hull, Tracy
    Steele, Scott
    Holubar, Stefan
    Rieder, Florian
    INFLAMMATORY BOWEL DISEASES, 2021, 27 : S15 - S16
  • [48] Infantile-onset inflammatory bowel disease has variable long-term outcomes
    Krauthammer, Alex
    Weintraub, Ilana
    Shaoul, Ron
    Lev-Tzion, Raffi
    Broide, Efrat
    Wilschanski, Michael
    Lerner, Aaron
    Yerushalmi, Baruch
    Shouval, Dror S.
    Shamaly, Hussein
    Haberman-Ziv, Yael
    Weiss, Batia
    FRONTIERS IN PEDIATRICS, 2023, 11
  • [49] IS ILEOANAL POUCH EXCISION A DESTINATION THERAPY FOR INFLAMMATORY BOWEL DISEASE? DATA FROM A QUATERNARY POUCH REFERRAL CENTER
    Choi, Sarah
    Lightner, Amy L.
    Lipman, Jeremy M.
    Hull, Tracy L.
    Steele, Scott
    Holubar, Stefan D.
    GASTROENTEROLOGY, 2021, 160 (06) : S873 - S874
  • [50] IS ILEOANAL POUCH EXCISION A DESTINATION THERAPY FOR INFLAMMATORY BOWEL DISEASE? DATA FROM A QUATERNARY POUCH REFERRAL CENTER
    Choi, Sarah
    Lightner, Amy
    Lipman, Jeremy
    Hull, Tracy
    Steele, Scott
    Holubar, Stefan
    Rieder, Florian
    GASTROENTEROLOGY, 2021, 160 (03) : S20 - S21